Rheumatoid Arthritis

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
BACKGROUND: The optimal first-line treatment in early rheumatoid arthritis (RA) is debated. We compared clinical and radiographic …
Mikkel Østergaard, Ronald F. van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf Heiberg, Dan C. Nordström, Michael T. Nurmohamed, Bjorn Gudbjornsson, Lykke Midtbøll Ørnbjerg, Pernille Bøyesen, Kristina Lend, Kim Hørslev-Petersen, Till Uhlig, Tuulikki Sokka, Gerdur Grondal, Simon Krabbe, Joakim Lindqvist, Inger Gjertsson, Daniel Glinatsi, Meliha Crnkic Kapetanovic, Anna-Birgitte Aga, Francesca Faustini, Pinja Parmanne, Tove Lorenzen, Cagnotto Giovanni, Johan Back, Oliver Hendricks, Daisy Vedder, Tuomas Rannio, Emma Grenholm, Maud Kristine Ljoså, Eli Brodin, Hanne Lindegaard, Annika Söderbergh, Milad Rizk, Alf Kastbom, Per Larsson, Line Uhrenholt, Søren Andreas Just, David J. Stevens, Trine Bay Laurbjerg, Gunnstein Bakland, Inge Christoffer Olsen, Espen A. Haavardsholm, Jon Lampa, NORD-STAR study group
Cite DOI
Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry
OBJECTIVE: To describe the outcomes of MTX and biologic DMARD (bDMARD) treatment in patients with RA and assess unmet needs in patients …
Inge C. Olsen, Elisabeth Lie, Radu Vasilescu, Gene Wallenstein, Sander Strengholt, Tore K. Kvien
Cite DOI
Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases
OBJECTIVES: Patients with inflammatory joint diseases (IJD) have an increased risk of cardiovascular disease (CVD). Our goal was to …
Eirik Ikdahl, Grunde Wibetoe, Silvia Rollefstad, Anne Salberg, Kjetil Bergsmark, Tore K. Kvien, Inge C. Olsen, Dag Magnar Soldal, Gunnstein Bakland, Åse Lexberg, Bjørg Tilde Svanes Fevang, Hans Christian Gulseth, Glenn Haugeberg, Anne Grete Semb
Cite DOI
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
OBJECTIVES: Recent studies suggest that implementation of the 2010 American College of Rheumatology (ACR)/European League Against …
Lena Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Elisabeth Lie, Hilde Berner Hammer, Till Uhlig, Désirée van der Heijde, Tore K. Kvien, Espen A. Haavardsholm
Cite DOI
Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project
OBJECTIVE: The European League Against Rheumatism recommends implementing cardiovascular disease (CVD) risk assessments for patients …
Eirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, Anne Salberg, Frode Krøll, Kjetil Bergsmark, Tore K. Kvien, Inge C. Olsen, Dag Magnar Soldal, Gunnstein Bakland, Åse Lexberg, Clara G. Gjesdal, Christian Gulseth, Glenn Haugeberg, Anne Grete Semb
Cite DOI
Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study
OBJECTIVE: When initiating a new therapy in patients with rheumatoid arthritis (RA), current treatment recommendations suggest …
Vibeke Norvang, Joseph Sexton, Eirik K. Kristianslund, Inge C. Olsen, Till Uhlig, Gunnstein Bakland, Frode Krøll, Erik Rødevand, Ada Wierød, Tore K. Kvien, Josef S. Smolen, Daniel Aletaha, Espen A. Haavardsholm
Cite DOI
Cardiovascular disease risk profiles in inflammatory joint disease entities
BACKGROUND: Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare …
Grunde Wibetoe, Eirik Ikdahl, Silvia Rollefstad, Inge C. Olsen, Kjetil Bergsmark, Tore K. Kvien, Anne Salberg, Dag Magnar Soldal, Gunnstein Bakland, Åse Lexberg, Bjørg-Tilde Fevang, Hans Christian Gulseth, Glenn Haugeberg, Anne Grete Semb
Cite DOI
Calcium supplementation and inflammation increase mortality in rheumatoid arthritis: A 15-year cohort study in 609 patients from the Oslo Rheumatoid Arthritis Register
OBJECTIVE: To investigate whether osteoporosis or use of calcium supplementations predict all-cause mortality, or death from CVD, in a …
Sella A. Provan, Inge C. Olsen, Cathrine Austad, Glenn Haugeberg, Tore K. Kvien, Till Uhlig
Cite DOI
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria
OBJECTIVES: To compare the presentation of seropositive and seronegative early rheumatoid arthritis (RA) in disease-modifying …
Lena Bugge Nordberg, Siri Lillegraven, Elisabeth Lie, Anna-Birgitte Aga, Inge Christoffer Olsen, Hilde Berner Hammer, Till Uhlig, Maria Karolina Jonsson, Désirée van der Heijde, Tore K. Kvien, Espen Andre Haavardsholm, and the ARCTIC working group
Cite DOI
The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis
BACKGROUND: The association of hypertension with asymptomatic cardiovascular organ damage in patients with rheumatoid arthritis (RA) …
Helga Midtbø, Eva Gerdts, Tore K. Kvien, Inge C. Olsen, Mai Tone Lønnebakken, Einar Skulstad Davidsen, Silvia Rollefstad, Anne Grete Semb
Cite DOI